Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1969 1
1974 1
1975 2
1978 1
1980 2
1981 2
1982 2
1983 3
1984 9
1985 10
1986 1
1987 4
1990 4
1991 1
1992 3
1993 5
1994 3
1995 1
1996 5
1997 3
1998 2
1999 3
2001 1
2002 1
2004 2
2005 4
2006 3
2007 1
2008 5
2009 4
2010 2
2012 2
2013 2
2014 1
2015 2
2016 1
2017 6
2018 6
2019 4
2020 1
2022 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

114 results

Results by year

Filters applied: . Clear all
Page 1
Meta-analysis of concomitant versus sequential radiochemotherapy in locally advanced non-small-cell lung cancer.
Aupérin A, Le Péchoux C, Rolland E, Curran WJ, Furuse K, Fournel P, Belderbos J, Clamon G, Ulutin HC, Paulus R, Yamanaka T, Bozonnat MC, Uitterhoeve A, Wang X, Stewart L, Arriagada R, Burdett S, Pignon JP. Aupérin A, et al. Among authors: clamon g. J Clin Oncol. 2010 May 1;28(13):2181-90. doi: 10.1200/JCO.2009.26.2543. Epub 2010 Mar 29. J Clin Oncol. 2010. PMID: 20351327 Review.
Beta blockade as adjunctive breast cancer therapy: A review.
Phadke S, Clamon G. Phadke S, et al. Among authors: clamon g. Crit Rev Oncol Hematol. 2019 Jun;138:173-177. doi: 10.1016/j.critrevonc.2019.04.006. Epub 2019 Apr 18. Crit Rev Oncol Hematol. 2019. PMID: 31092374 Review.
The clinical significance of soluble PD-1 and PD-L1 in lung cancer.
Abu Hejleh T, Furqan M, Ballas Z, Clamon G. Abu Hejleh T, et al. Among authors: clamon g. Crit Rev Oncol Hematol. 2019 Nov;143:148-152. doi: 10.1016/j.critrevonc.2019.08.009. Epub 2019 Sep 11. Crit Rev Oncol Hematol. 2019. PMID: 31675543 Review.
A Phase I Study of Apolizumab, an Anti-HLA-DR ß-chain Monoclonal Antibody, in Patients With Solid Tumor Malignancies.
Fracasso PM, Goodner SA, Wildi JD, Naughton MJ, Linette GP, Govindan R, Tan BR, Blum KA, Jones GJ, Pearce TE, Levitt DJ, Clamon GH. Fracasso PM, et al. Among authors: clamon gh. Am J Clin Oncol. 2022 Jul 1;45(7):294-297. doi: 10.1097/COC.0000000000000924. Epub 2022 Jun 1. Am J Clin Oncol. 2022. PMID: 35700081 Free PMC article. Clinical Trial.
114 results